N 6 -methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming

Kun Zhang,Tao Zhang,Yuhan Yang,Wenling Tu,Hongbin Huang,Yujun Wang,Yuzhuo Chen,Kejian Pan,Zhuojia Chen
DOI: https://doi.org/10.7150/thno.73746
IF: 11.6
2022-01-01
Theranostics
Abstract:<b>Background:</b> Chemoresistance to 5-fluorouracil (5-FU) is a major barrier to influence the treatment efficiency of colorectal cancer (CRC) patients, while the precise molecular mechanisms underlying 5-FU resistance remain to be fully elucidated. <b>Methods:</b> The metabolic profiles including ATP generation, glucose consumption, lactate generation, and oxygen consumption rate (OCR) in 5-FU resistant CRC cells were compared with those in their parental cells. Subsequently, a series of <i>in vitro</i> and <i>in vivo</i> experiments were carried out to investigate the mechanisms responsible for metabolic reprogramming of 5-FU resistant CRC cells. <b>Results:</b> We found that 5-FU resistant CRC cells showed increased levels of ATP generation, glucose consumption, lactate generation, and OCR as compared with those in their parental cells. Further, increased levels of mRNA N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) and methyltransferase-like 3 (METTL3) were observed in 5-FU resistant CRC cells. Inhibition or knockdown of METTL3 can suppress glycolysis and restore chemosensitivity of 5-FU resistant CRC cells. Mechanistically, METTL3 enhances the expression of LDHA, which catalyzes the conversion of pyruvate to lactate, to trigger glycolysis and 5-FU resistance. METTL3 can increase the transcription of LDHA via stabilizing mRNA of hypoxia-inducible factor (HIF-1α), further, METTL3 also triggers the translation of LDHA mRNA via methylation of its CDS region and recruitment of YTH domain-containing family protein 1 (YTHDF1). Targeted inhibition of METTL3/LDHA axis can significantly increase the <i>in vitro</i> and <i>in vivo</i> 5-FU sensitivity of CRC cells. <b>Conclusion:</b> Our study indicates that METTL3/LDHA axis-induced glucose metabolism is a potential therapy target to overcome 5-FU resistance in CRC cells.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how N6 - methyladenosine (m6A) - mediated lactate dehydrogenase A (LDHA) induction in 5 - fluorouracil (5 - FU) - resistant colorectal cancer (CRC) cells enhances chemoresistance through metabolic reprogramming. Specifically, the study aims to reveal the mechanism of action of m6A modification and its related regulatory factors such as METTL3 in 5 - FU - resistant CRC cells, especially how they affect the glycolytic pathway and cell sensitivity to 5 - FU. ### Research Background - **5 - FU Resistance**: 5 - Fluorouracil (5 - FU) is a first - line drug for the treatment of advanced and metastatic colorectal cancer, but resistance is a major obstacle affecting the treatment effect. - **Metabolic Reprogramming**: Studies have shown that metabolic reprogramming plays a key role in the malignant progression of cancer, especially in relation to chemoresistance. 5 - FU - resistant CRC cells exhibit an enhanced glycolytic phenotype. ### Research Methods - **Metabolic Feature Analysis**: Compare the differences in ATP production, glucose consumption, lactate production and oxygen consumption rate (OCR) between 5 - FU - resistant CRC cells and their parental cells. - **Experimental Verification**: Explore the mechanism of action of METTL3 in 5 - FU - resistant CRC cells through in vitro and in vivo experiments. ### Main Findings - **Metabolic Feature Changes**: 5 - FU - resistant CRC cells show higher ATP production, glucose consumption, lactate production and OCR. - **Increased m6A Levels**: The m6A levels and METTL3 expression in 5 - FU - resistant CRC cells are significantly increased. - **METTL3 Regulates LDHA**: METTL3 enhances LDHA expression by stabilizing HIF - 1α mRNA and methylating the CDS region of LDHA mRNA, thereby triggering glycolysis and 5 - FU resistance. - **Inhibition of METTL3/LDHA Axis**: Targeted inhibition of the METTL3/LDHA axis can significantly improve the sensitivity to 5 - FU, both in vitro and in vivo experiments. ### Conclusion - **Potential Therapeutic Targets**: The research results indicate that glucose metabolism induced by the METTL3/LDHA axis may be a potential therapeutic target for overcoming 5 - FU resistance. ### Keywords - Glycolysis - METTL3 - 5 - FU - LDHA - Chemoresistance Through these findings, the study provides new insights into understanding the molecular mechanisms of 5 - FU - resistant CRC and a theoretical basis for the development of new treatment strategies.